Retatrutide

Retatrutide Australia and New Zealand (LY3437943): triple agonist research peptide

Retatrutide is a synthetic research peptide (a lab-made chain of amino acids, the building blocks of proteins), also known by its development code LY3437943 and sometimes shortened to “Reta.” It is a triple agonist (also called a tri-agonist): one peptide that acts on three receptors at once, GIP, GLP-1 and glucagon. AusBioLabs supplies the Retatrutide peptide in Australia and New Zealand as a lyophilised (freeze-dried) powder for in-vitro (test-tube and cell) laboratory research only.

Retatrutide at a glance

• Compound: Retatrutide (LY3437943), a triple GIP/GLP-1/glucagon agonist research peptide.
• Purity & testing: over 99% by HPLC (latest batch 99.8%), third-party tested by Janoshik, with a CoA per batch.
• Form: white lyophilised (freeze-dried) powder in a sealed vial.
• Sizes: 10mg, 20mg, 30mg and 50mg vials, single, with a starter kit, or as a 10x bulk pack.
• Shipping: same-day dispatch from Sydney on orders before 12pm AEST, free express over $200.

What is Retatrutide, and is it a peptide?

Yes, Retatrutide is a peptide, made in a lab to a fixed sequence, so it is synthetic, not a steroid, and not taken from a plant or animal. What makes the Retatrutide peptide stand out is its triple agonist design. An agonist is a molecule that switches a receptor on. Where most peptides here switch on one or two, Retatrutide switches on three at once: the GIP, GLP-1 and glucagon receptors. All three are studied together in metabolic research, so Retatrutide is examined as a triple-target compound rather than one receptor at a time.

How is Retatrutide studied in research?

Because Retatrutide acts on three receptors from a single molecule, researchers use it to study how these pathways behave together. In a typical in-vitro study, scientists measure how strongly the peptide switches on each receptor and the signal the cell sends back. Retatrutide is most potent at the GIP receptor, then GLP-1, then glucagon (reported EC50 values of about 0.06, 0.8 and 5.8 nM, where a lower number means less peptide is needed to switch the receptor on). Having all three actions in one molecule makes it a useful reference point against one-receptor or two-receptor peptides.

Is Retatrutide approved? Research status explained

Retatrutide is an investigational compound: still being studied, and not approved by the Therapeutic Goods Administration (TGA, Australia’s medicines regulator), the FDA, or any other regulator for medical, veterinary or personal use. AusBioLabs supplies it strictly as a laboratory reference material. It is not a medicine, a supplement, a cosmetic or a consumer product of any kind, and nothing on this page is medical advice or usage guidance. It is sold only to qualified researchers who handle it under proper laboratory conditions.

Where Retatrutide fits in metabolic research

Laboratories use the Retatrutide peptide as a steady reference compound in metabolic and receptor research, and it sits within our Metabolic Research range. It is also a common comparison point: researchers place a triple agonist next to single-receptor and dual-receptor peptides such as Tirzepatide to see how the extra glucagon action changes the result. Every use described here stays in-vitro, in test tubes and cell cultures.

Retatrutide purity, third-party testing and the CoA

Before a batch goes on sale, AusBioLabs has Retatrutide checked by Janoshik, an independent third-party laboratory. Purity is read by HPLC (high-performance liquid chromatography, which separates a sample so the share of the target compound can be measured) and comes in above 99%, with the latest batch at 99.8%. Identity is confirmed by a blind test, in which the sample is placed among other GLP-1 peptides and must be picked out correctly as Retatrutide.

Recent batches are also screened by Janoshik for:

• Endotoxins (contaminants left behind by bacteria): under 1 EU per vial.
• Heavy metals (arsenic, cadmium, lead and mercury): all not detected.

Every order ships with its batch Certificate of Analysis (CoA), and each Janoshik report can be checked on the Janoshik website using the unique key printed on it.

Buy Retatrutide in Australia and New Zealand: sizes and shipping

• AusBioLabs is an Australian-owned supplier that holds stock in Australia, so Retatrutide bought here ships within the country with no customs delays.
• Available for sale in 10mg, 20mg, 30mg and 50mg vials, on their own or with a starter kit; for larger research quantities, the 10x Retatrutide bulk pack is also available.
• Buy Retatrutide online in Australia and New Zealand before 12pm AEST for same-day dispatch from Sydney by tracked Australia Post Express.
• Delivery usually takes 2 to 4 business days for VIC, NSW, QLD, NT and SA, 4 to 6 business days for WA, and 4 to 6 business days for New Zealand.
• Express shipping is free on orders over $200, and every order includes the batch Certificate of Analysis.

How to store and reconstitute Retatrutide

• Retatrutide ships as a lyophilised (freeze-dried) powder, which keeps best cold and dry.
• Store the sealed vial below 25°C and away from light for short periods, or at about -20°C for longer storage.
• To reconstitute (mix the powder into a liquid), laboratories usually use sterile or bacteriostatic water under clean, sterile conditions.
• Once mixed, keep the solution in the fridge and use it within a few weeks.
• Repeated freezing and thawing can break the peptide down, so many labs divide it into smaller portions before freezing.

Retatrutide technical specifications

Retatrutide FAQs

What is Retatrutide (LY3437943)?

Retatrutide is a synthetic research peptide and a triple agonist, meaning it acts on three receptors at once: GIP, GLP-1 and glucagon. It was developed under the code LY3437943 and is studied in test-tube and cell (in-vitro) research into metabolic pathways.

Is Retatrutide a peptide or a steroid?

It is a peptide, not a steroid. Retatrutide is a synthetic chain of amino acids with a molecular weight of about 4731 g/mol, which places it firmly in the peptide group.

How pure is AusBioLabs Retatrutide?

The latest batch tested 99.8% pure by HPLC (over 99%). Identity is confirmed by a blind test against other GLP-1 peptides, and recent batches have also been screened for endotoxins (under 1 EU per vial) and heavy metals (not detected). Every order includes the batch Certificate of Analysis from the independent lab Janoshik.

What is Retatrutide used for in research?

In the lab, Retatrutide is used as a reference compound for studying the GIP, GLP-1 and glucagon receptors together, and as a comparison point against peptides that reach only one or two receptors. All of this work is in-vitro, in test tubes and cell cultures, never in people or animals.

How should Retatrutide be stored?

Keep the sealed powder below 25°C and out of light for short-term storage, or near -20°C for longer periods. After it is mixed with sterile or bacteriostatic water, keep it in the fridge and avoid repeated freezing and thawing.

Can I buy Retatrutide in Australia and New Zealand?

Yes. AusBioLabs holds stock in Australia and ships to both Australia and New Zealand from Sydney by tracked Australia Post Express, with same business day dispatch on orders placed before 12pm AEST. It is supplied for laboratory research only.

What sizes are available?

Retatrutide comes in 10mg, 20mg, 30mg and 50mg vials, on their own or with a starter kit, plus a 10x bulk pack for larger research quantities. The mg is the amount of powder in the vial, not a dose.

Is Retatrutide approved for human or medical use?

No. Retatrutide is an investigational compound supplied strictly as a research chemical. It has not been approved by the TGA or any other regulator for human treatment or veterinary use.

Disclaimer: Retatrutide is sold for in-vitro laboratory research only. It is not a medicine, supplement, or cosmetic, and it is not for human or animal use. By buying, you confirm you are a qualified researcher and will handle and store it in line with all applicable Australian and New Zealand laws and safety rules.